• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2002年至2005年在法国分离出的A/H3N2流感病毒对抗病毒药物敏感性的演变

Evolution of the susceptibility to antiviral drugs of A/H3N2 influenza viruses isolated in France from 2002 to 2005.

作者信息

Ferraris Olivier, Kessler Nicole, Valette Martine, Lina Bruno

机构信息

Laboratoire de Virologie, Centre National de Référence pour la Grippe (France-Sud), Domaine Rockefeller, 8 avenue Rockefeller, 69373 Lyon Cedex 08, France.

出版信息

Vaccine. 2006 Nov 10;24(44-46):6656-9. doi: 10.1016/j.vaccine.2006.05.050. Epub 2006 Jun 8.

DOI:10.1016/j.vaccine.2006.05.050
PMID:16797804
Abstract

In 2002, prior to the generalization of zanamivir and oseltamivir utilization in France, we had decided to test a large panel of influenza strains to establish the baseline sensitivity of these viruses to anti-neuraminidase drugs. Since 2002, routine monitoring of resistance relies mainly on the results of neuraminidase enzyme assay. The profile of sensitivity of A/H3N2 viruses has not changed during these three influenza seasons. Neuraminidase N2 was shown to be more sensitive to oseltamivir carboxylate than to zanamivir. Amongst 788 viruses tested, only 10 were found with outliers IC(50) values (seven in 2003, one in 2004, and two in 2005). After the sequencing of the neuraminidase segment of these viruses, seven mutations on the stalk or the head of the glycoprotein (A18S, L23F, C42R, R143V, E199K, S332K, R431N) were detected. Moreover during seasons 2003-2005, 12 additional viruses were characterized by a complete lack of neuraminidase activity. In these viruses, viral resistance to NA inhibitors can be related with the presence of a defective neuraminidase RNA segment as evaluated by a plaque reduction assay, these viruses having a reduced dependence on its neuraminidase activity.

摘要

2002年,在法国推广扎那米韦和奥司他韦使用之前,我们决定对大量流感毒株进行检测,以确定这些病毒对抗神经氨酸酶药物的基线敏感性。自2002年以来,耐药性的常规监测主要依赖神经氨酸酶酶活性测定的结果。在这三个流感季节中,A/H3N2病毒的敏感性概况没有变化。神经氨酸酶N2对奥司他韦羧酸盐比对扎那米韦更敏感。在检测的788株病毒中,仅发现10株具有异常的IC(50)值(2003年7株,2004年1株,2005年2株)。对这些病毒的神经氨酸酶片段进行测序后,在糖蛋白的柄部或头部检测到7个突变(A18S、L23F、C42R、R143V、E199K、S332K、R431N)。此外,在2003 - 2005年流感季节期间,又有12株病毒表现为完全缺乏神经氨酸酶活性。在这些病毒中,通过蚀斑减少试验评估,病毒对神经氨酸酶抑制剂的耐药性可能与存在缺陷的神经氨酸酶RNA片段有关,这些病毒对其神经氨酸酶活性的依赖性降低。

相似文献

1
Evolution of the susceptibility to antiviral drugs of A/H3N2 influenza viruses isolated in France from 2002 to 2005.2002年至2005年在法国分离出的A/H3N2流感病毒对抗病毒药物敏感性的演变
Vaccine. 2006 Nov 10;24(44-46):6656-9. doi: 10.1016/j.vaccine.2006.05.050. Epub 2006 Jun 8.
2
Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice.流感病毒对扎那米韦和奥司他韦的敏感性:一项针对在临床实践中引入神经氨酸酶抑制剂之前在法国流行的病毒所开展的研究。
Antiviral Res. 2005 Oct;68(1):43-8. doi: 10.1016/j.antiviral.2005.07.004.
3
Neuraminidase inhibitor susceptibility of porcine H3N2 influenza A viruses isolated in Germany between 1982 and 1999.1982年至1999年间在德国分离出的猪源甲型H3N2流感病毒的神经氨酸酶抑制剂敏感性
Antiviral Res. 2007 Sep;75(3):219-26. doi: 10.1016/j.antiviral.2007.03.007. Epub 2007 Apr 3.
4
Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro.在人类流感病毒N2神经氨酸酶中赋予扎那米韦抗性的突变会损害病毒适应性,并且在体外不能稳定维持。
J Antimicrob Chemother. 2006 Oct;58(4):723-32. doi: 10.1093/jac/dkl321. Epub 2006 Aug 5.
5
Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes.神经氨酸酶抑制剂A-315675对N1和N2亚型耐奥司他韦流感神经氨酸酶的活性。
Antiviral Res. 2008 Feb;77(2):163-6. doi: 10.1016/j.antiviral.2007.08.008. Epub 2007 Sep 10.
6
Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors.对神经氨酸酶抑制剂敏感性降低的甲型(H1N1)和乙型人流感毒株的检测
J Clin Virol. 2008 Jan;41(1):25-8. doi: 10.1016/j.jcv.2007.10.019. Epub 2007 Dec 4.
7
Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.2009-2010 年和 2010-2011 年流感季节日本大流行和季节性流感病毒的神经氨酸酶抑制剂敏感性特征。
Antiviral Res. 2013 Sep;99(3):261-9. doi: 10.1016/j.antiviral.2013.06.003. Epub 2013 Jun 17.
8
Different neuraminidase inhibitor susceptibilities of human H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany from 2001 to 2005/2006.2001年至2005年/2006年在德国分离出的甲型H1N1、H1N2和H3N2流感病毒对神经氨酸酶抑制剂的敏感性差异。
Antiviral Res. 2009 Apr;82(1):34-41. doi: 10.1016/j.antiviral.2009.01.006. Epub 2009 Feb 6.
9
Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007.1996 - 2007年日本对神经氨酸酶抑制剂耐药流感病毒的监测
Antivir Ther. 2009;14(6):751-61. doi: 10.3851/IMP1194.
10
Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir.来自澳大拉西亚和东南亚的人类流感病毒对神经氨酸酶抑制剂扎那米韦和奥司他韦的敏感性。
Antiviral Res. 2004 Apr;62(1):37-45. doi: 10.1016/j.antiviral.2003.11.008.

引用本文的文献

1
Revisiting influenza A virus life cycle from a perspective of genome balance.从基因组平衡的角度重新审视甲型流感病毒的生命周期。
Virol Sin. 2023 Feb;38(1):1-8. doi: 10.1016/j.virs.2022.10.005. Epub 2022 Oct 27.
2
Competitive Cooperation of Hemagglutinin and Neuraminidase during Influenza A Virus Entry.流感病毒进入时血凝素和神经氨酸酶的竞争合作。
Viruses. 2019 May 20;11(5):458. doi: 10.3390/v11050458.
3
Influenza Virus Neuraminidase Structure and Functions.流感病毒神经氨酸酶的结构与功能
Front Microbiol. 2019 Jan 29;10:39. doi: 10.3389/fmicb.2019.00039. eCollection 2019.
4
Rescue of a H3N2 influenza virus containing a deficient neuraminidase protein by a hemagglutinin with a low receptor-binding affinity.通过具有低受体结合亲和力的血凝素拯救含有缺陷神经氨酸酶蛋白的 H3N2 流感病毒。
PLoS One. 2012;7(5):e33880. doi: 10.1371/journal.pone.0033880. Epub 2012 May 1.
5
Deletions of neuraminidase and resistance to oseltamivir may be a consequence of restricted receptor specificity in recent H3N2 influenza viruses.神经氨酸酶缺失及对奥司他韦的耐药性可能是近期H3N2流感病毒受体特异性受限的结果。
Virol J. 2009 Feb 14;6:22. doi: 10.1186/1743-422X-6-22.